HOUSTON, March 29, 2024 /PRNewswire/ -- The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with Labcorp (NYSE: LH), a global leader of innovative diagnostic and biopharma laboratory services, to serve as its Preferred Genetic Carrier Screening Lab..

休斯顿，2024年3月29日/PRNewswire/--北美最大的生育诊所网络Prelude Network®（Prelude）今天宣布，将扩大与创新诊断和生物制药实验室服务全球领导者Labcorp（纽约证券交易所：LH）的合作伙伴关系，作为其首选的基因载体筛选实验室。。

Labcorp has long been a partner to Prelude and its expansive network of more than 90 clinics across the U.S. and in parts of Canada, providing clinical laboratory and FDA-approved donor testing within each clinic. The expansion of this partnership delivers another level of genetic carrier screening services to Prelude patients, including in-office phlebotomists and patient service centers.

Labcorp长期以来一直是Prelude及其在美国和加拿大部分地区拥有90多家诊所的庞大网络的合作伙伴，在每家诊所内提供临床实验室和FDA批准的捐赠者检测。这种合作关系的扩大为前奏患者提供了另一级的基因携带者筛查服务，包括办公室静脉切开术和患者服务中心。

Additionally, Labcorp offers comprehensive genetic counseling, services for provider questions, and complimentary review of carrier screening results for patients. It also capitalizes on a pre-existing interface with electronic medical records for ordering and reporting carrier screening results, improved clarity on reports with variant-specific interpretation, and highly competitive network contract rates for other genetic tests.

此外，Labcorp还提供全面的遗传咨询、提供者问题服务以及对患者携带者筛查结果的免费审查。它还利用预先存在的与电子病历的接口来订购和报告携带者筛查结果，提高了具有特定变体解释的报告的清晰度，以及其他基因检测的极具竞争力的网络合同费率。

To improve financial access to genetic carrier screening for the U.S. patient population, Labcorp is contracted with many insurance companies..

为了改善美国患者人群进行基因携带者筛查的财务渠道，Labcorp与许多保险公司签订了合同。。

'Genetic screening is a vital part of fertility diagnostics as it helps patients and physicians make critical decisions on care and treatment options that lead to optimal outcomes,' says TJ Farnsworth, Founder and CEO of Inception Fertility™, the parent company to The Prelude Network. 'By expanding our partnership with Labcorp, we're able to deliver a higher level of care to those patients who require genetic screening services to build their families, and we're excited to work closely with Labcorp to improve accessibility and the patient experience.'.

Prelude Network母公司Inception fertility™的创始人兼首席执行官TJ Farnsworth说：“基因筛查是生育诊断的重要组成部分，因为它可以帮助患者和医生做出关键的护理和治疗选择，从而取得最佳结果。通过扩大与Labcorp的合作伙伴关系，我们能够为那些需要基因筛查服务才能建立家庭的患者提供更高水平的护理，我们很高兴与Labcorp密切合作，以改善可及性和患者体验。”。

This expanded partnership also supports Prelude's Genetic Center of Excellence program and its commitment to offering best-in-class services to patients incorporating genetic testing as part of their care plans. Launched in 2022, one of the initiatives of the Genetic Center of Excellence is to establish standardized, high-quality genetic screening for patients and egg donors in Prelude's network..

这种扩大的合作伙伴关系还支持Prelude的卓越遗传中心计划，并支持其承诺为将基因检测纳入其护理计划的患者提供一流的服务。卓越遗传中心于2022年启动，其举措之一是在Prelude的网络中为患者和卵子捐献者建立标准化的高质量基因筛查。。

'Prelude is excited to offer our patients greater access to best-in-class genetic carrier screening,' says Lauri Black, Certified Genetic Counselor and Director of Genetic Services at Inception. 'It is our belief that by appointing Labcorp as The Prelude Network's Preferred Genetic Carrier Screening Lab, we can build on our efforts to give every aspiring parent a greater chance at bringing home a healthy baby.'.

“Prelude很高兴能为我们的患者提供更多的机会进行一流的基因携带者筛查，”Lauri Black说，他是注册遗传咨询师兼基因服务主管我们相信，通过任命Labcorp作为Prelude Network首选的基因携带者筛查实验室，我们可以在我们的努力基础上，为每一位有抱负的父母提供更大的机会，让他们带回家一个健康的孩子。”。

To learn more about Prelude clinics, that span across the US and part of Canada, please visit preludefertility.com.

要了解跨越美国和加拿大部分地区的Prelude诊所的更多信息，请访问preludefertility.com。

About The Prelude Network®

关于Prelude Network®

The Prelude Network® (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility™ – a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility..

Prelude Network®（Prelude）是北美增长最快的生育诊所网络和最大的综合生育服务提供商，是Inception fertility™的诊所网络，它是一个生育品牌家族，涉及生育过程的每个部分，包括诊断和治疗，以获得财务支持。。

Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on an excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others..

作为序曲的一部分，每家诊所都致力于通过专注于卓越的科学，医学和患者体验，为国家领先的生殖内分泌学家，胚胎学家和从业者提供最高水平的个性化生育护理。不断增长的Prelude网络在全国共有90多个地点，提供广泛的生育服务，包括卵子冷冻、体外受精、基因检测、LGBTQ+生育选择以及卵子/胚胎储存等。。

Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility McAllen (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida)..

Prelude内的这些诊所包括Aspire Fertility Austin（德克萨斯州）；Aspire Fertility达拉斯（德克萨斯州）；Aspire Fertility McAllen（德克萨斯州）；Aspire Fertility圣安东尼奥（德克萨斯州）；Aspire休斯顿生育研究所（德克萨斯州）；芝加哥高级生育中心（伊利诺伊州）；生殖医学中心（佛罗里达）；印第安纳州生育研究所（印第安纳州）；IVFMD（佛罗里达州）；主线生育率（宾夕法尼亚州）；纽约大学朗根生育中心（纽约）；纽约大学Langone RSNY（纽约）；太平洋生殖医学中心（加拿大）；太平洋生育中心（加利福尼亚）；区域生育计划（加拿大）；生殖生物学协会（格鲁吉亚）；田纳西州生育研究所（田纳西州）和生殖医学集团（佛罗里达州）。。

About Inception Fertility™ Inception Fertility™ (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. .

关于Inception Fertility™Inception Fertility™（Inception）是一个生育品牌家族，致力于帮助患者建立自己的家庭。由患者为患者打造，Inception的目的是在经验、科学和医学方面达到最高标准，以提高每位患者的体验并取得更好的结果。。

Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) – including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services – and they continue to lead the industry by building on these technologies by through development, research and thought leadership..

《盗梦空间》的医学专家是生育护理领域的领先先驱。我们的医生是第一批使用突破性辅助生殖技术（ART）的人，包括体外受精（IVF）、植入前基因检测（PGT）和生育保存服务，他们通过开发、研究和思维领导力，在这些技术的基础上继续引领行业。。

Through its growing family of national organizations – which includes The Prelude Network®, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; Pathways Fertility, clinics that provide affordable, individualized and high quality care; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception – Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations..

通过其不断壮大的国家组织家族，其中包括Prelude Network®，这是北美增长最快的生育诊所网络和最大的综合生育服务提供商；Pathways生育，提供负担得起的，个性化和高质量护理的诊所；MyEggBank®，北美最大的冷冻供体卵库之一；Bundle Fertility™是一个多周期生育服务捆绑计划；HavenCryo™是一家长期的生殖保存和储存解决方案提供商，NutraBloom®是一家优质的生活方式品牌，通过专业配方的补充剂来支持个人的孕前健康目标–Inception正在努力兑现其承诺，推动超越患者期望的可能性。。

About LabcorpLabcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities.

关于LabcorpLabcorp（纽约证券交易所代码：LH）是创新和综合实验室服务的全球领导者，可帮助医生、医院、制药公司、研究人员和患者做出明确而自信的决定。我们通过无与伦比的诊断和药物开发实验室能力，为改善健康和改善生活提供见解和先进科学。

The company's more than 67,000 employees serve clients in over 100 countries, worked on over 84% of the new drugs approved by the FDA in 2023 and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com..

该公司有67000多名员工为100多个国家的客户提供服务，2023年FDA批准的新药中有84%以上是由该公司研发的，并为全球患者进行了6亿多次检测。有关我们的更多信息，请访问www.labcorp.com。。